BridgeMD
New treatment option for Infection
Official title Quality Improvement Intervention for a Safe Antimicrobial Use Reduction in Critically Ill Patients
ClinicalTrials.gov ID: NCT07093450
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if an educational intervention with audit and feedback on physicians and health care professionals who participate in antimicrobial treatment decisions can reduce the use of antimicrobials in adult patients admitted to a sample of Brazilian intensive care units (ICUs). The educational intervention is based on a literature review of current recommendations for a more rational use of antimicrobials and microbiological tests in daily ICU practice.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Intensive care units
- ICU leadership acceptance to participant in the quality improvement intervention;
- Hospital infection control leadership acceptance to participant in the quality improvement intervention;
- ICU participation in the IMPACTO-MR platform with high quality data;
- ICU potential for quality improvement based on a subjective assessment of the ICU and hospital infection leaderships Intensive care units
You likely can't join if
- \- Absence of local IRB approval Participants inclusion Criteria:
- All patients admitted to the intensive care unit Participants exclusion Criteria:
- Patients younger than 18 years-old will be excluded from individual-level analysis
The study team makes the final eligibility decision.
Where it's taking place
- Colatina, Espírito Santo, Brazil
- Passos, Minas Gerais, Brazil
- Maringá, Paraná, Brazil
- Recife, Pernambuco, Brazil
- Rio de Janeiro, Rio de Janeiro, Brazil
- Natal, Rio Grande do Norte, Brazil
- Porto Alegre, Rio Grande do Sul, Brazil
- Santa Cruz do Sul, Rio Grande do Sul, Brazil
- Barretos, São Paulo, Brazil
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Colatina, Espírito Santo, Brazil; Passos, Minas Gerais, Brazil; Maringá, Paraná, Brazil; Recife, Pernambuco, Brazil; Rio de Janeiro, Rio de Janeiro, Brazil; Natal, Rio Grande do Norte, Brazil and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.